Raquel Fino Seiça
Raquel Fino Seiça
Professor at the Faculty of Medicine of the University of Coimbra.
Director of the Institute of Physiology of the FMUC and Integrated Researcher of the Institute for Clinical and Biomedical Research of Coimbra-iCBR-FMUC and of the Centre for Innovation in Biomedicine and Biotechnology- CIBB-UC, and Collaborating Researcher of the University of Coimbra’s Centre for Classical and Humanistic Studies and Centre for Physics.
Pedagogical activities focused on the area of Medical Physiological taught to the courses of Medicine, Dental Medicine, Biomedical Engineering and Medicinal Chemistry.
As main areas of interest are obesity and type 2 diabetes.
Selected Publications
Obesity and Brain Function, Advances in Neurobiology 19. Editores: Liliana Letra and Raquel Seiça. Springer International Publishing AG, 2017.
Pereira A, Fernandes R, Crisóstomo J, Seiça R, Sena CM, The Sulforaphane and pyridoxamine supplementation normalize endothelial dysfunction associated with type 2 diabetes. Sci Rep. 2017. doi: 10.1038/s41598-017-14733-x.
Matafome P, Rodrigues T, Sena C, Seiça R. Methylglyoxal in metabolic disorders: facts, myths and promises. Med Res Rev, 2017; 37: 368-403.
Rodrigues T, Almeida JP, Gamas L, Sereno JV, Castelhano JM, Neves CA, Gonçalves SI, Arslanagic A, Wilcken EH, Fonseca R, Simões I, Castelo-Branco M, Matafome P, Seiça R. Methylglyoxal-induced glycation changes adipose tissue vascular architecture, flow and expansion, leading to insulin resistance. Sci Rep 2017. doi: 10.1038/s41598-017-01730-3.
Crisóstomo J, Matafome P, Santos-Silva D, Gomes AL, Gomes M, Patrício M, Letra L, Sarmento-Ribeiro AB, Santos L, Seiça R. Hyperresistinemia and metabolic dysregulation: a risky crosstalk in obese breast cancer. Endocrine, 2016; 53: 433-442.